Equities research analysts forecast that Novavax, Inc. (NASDAQ:NVAX) will announce earnings of $0.36 per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Novavax's earnings. The highest EPS estimate is $7.89 and the lowest is ($4.95). Novavax reported earnings of ($2.70) per share during the same quarter last year, which suggests a positive year over year growth rate of 113.3%. The business is scheduled to announce its next quarterly earnings report on Monday, March 7th.
Laduree
Posts (179)
The South Africa travel ban is not lift yet. Just imagine once it’s lift, US cases will skyrocket
Cramer said he prefer Pfizer's stock because he needs their blue pills every single time
EU Medicines Agency
@EMA_News
#COVID19vaccines: Where are we now❓
➡️ 5 vaccines under evaluation: for 4 of them the #RollingReview is ongoing; the 5th – the Novavax vaccine - is on the last mile for a recommendation with a formally submitted marketing authorisation application
➡️ 4 vaccines authorised
2:30 AM · Dec 4, 2021·Meltwater Social
Burn all puts and wicked shorts today
A different kind of COVID vaccine is about ready to roll
December 1, 20211:46 PM ET
These new vaccines are what's called protein subunit vaccines. They work by injecting people with a tiny portion of the virus. In the case of the COVID-19 vaccine, that tiny portion is the so-called spike protein critical for the virus to enter cells.
I’ll travel from US to Australia to have my kids vaccinated there. Fuck FDA
156 was the new bottom. Tomorrow is OE days. Let the puts and shorts be burned
Tomorrow is OE day again. Let them kill all puts
After hour prices are pretty stable so far